medications are available
and affordable to all
Because eliminating shortages and high prices is in the best interest of patients.
Leading a movement for patients, not profits
Dedicated to making generic medicines and biosimilars affordable and available to everyone.
for hospitals
Civica has reliably supplied vital generic injectables to member hospitals since 2018. When shortages hit, our members stay stocked.
Millions of U.S. patients are treated with Civica medications every year.
Essential medications are made in our U.S. manufacturing facility.
Civica through
the years
2018
FOUNDED TO ADDRESS DRUG SHORTAGES
Civica established by health systems nationwide to stabilize supply and lower costs of essential generic medicine
FOUNDED TO ADDRESS DRUG SHORTAGES
Civica established by health systems nationwide to stabilize supply and lower costs of essential generic medicines
2019
FROM MISSION TO MEDICINE
First medication, vancomycin, distributed to member hospitals
Expanded access
to essential hospital generics nationwideFROM MISSION TO MEDICINE
First medication, vancomycin, distributed to member hospitals
Expanded access to essential hospital generics nationwide
2020
NATIONAL PANDEMIC RESPONSE
2.1 million vials supplied to the U.S. Strategic National Stockpile
340+ hospitals receiving Civica medications
NATIONAL PANDEMIC RESPONSE
2.1 million vials supplied to the U.S. Strategic National Stockpile
340+ hospitals receiving Civica medications
2021
FROM HOSPITALS TO EVERY PATIENT
Construction begins on Petersburg, Virginia manufacturing facility
CivicaScript launches to bring affordable generics to consumers
FROM HOSPITALS TO EVERY PATIENT
Construction begins on Petersburg, Virginia manufacturing facility
CivicaScript launches to bring affordable generics to consumers
2022
NEW LEADERSHIP & NEW FRONTIERS
Ned McCoy appointed Civica President & CEO
CivicaScript introduces first product, abiraterone acetate
Affordable insulin initiative launched by the Civica Foundation
NEW LEADERSHIP & NEW FRONTIERS
Ned McCoy appointed Civica President & CEO
CivicaScript introduces first product, abiraterone acetate
Affordable insulin initiative launched by the Civica Foundation
2023
GROWTH THROUGH PARTNERSHIPS & AWARENESS
Selected as manufacturing partner for CalRx’s Biosimilar Insulin Initiative
Exclusive distribution partnership established with AmerisourceBergen
Congressional testimony provided on drug shortages
GROWTH THROUGH PARTNERSHIPS & AWARENESS
Selected as manufacturing partner for CalRx’s Biosimilar Insulin Initiative
Exclusive distribution partnership established with AmerisourceBergen
Congressional testimony provided on drug shortages
2024
INCREASED CAPACITY & RECOGNITION
High-value filling lines installed at Petersburg plant
Best Place to Work awarded by BioSpace for the second year
INCREASED CAPACITY & RECOGNITION
High-value filling lines installed at Petersburg plant
Best Place to Work awarded by BioSpace for the second year
2025
NATIONWIDE INSULIN EXPANSION
Long-acting insulin launch announced for 2026
$3 million to advance insulin access granted by the Commonwealth of Virginia
NATIONWIDE INSULIN EXPANSION
Long-acting insulin launch announced for 2026
$3 million to advance insulin access granted by the Commonwealth of Virginia
